Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pterygopalatine fossa lidocaine plus epinephrine infiltration for bleeding control during endoscopic sinonasal surgery
IRCT20210307050609N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine and epinephrine in chronic rhinosinusitis (CRS) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Intraoperative blood volume and Surgical field grading using Boezaart scale. Started Apr 2021; status: completed.
02
Drugs
lidocaineepinephrine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on IRCT20210307050609N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210307050609N1.